4 Recruiting Advanced Clear Cell Renal Cell Carcinoma Phase 2 Clinical Trials

Active phase 2 studies for advanced clear cell renal cell carcinoma enrolling across the USA. Verify eligibility and contact site coordinators.

All Advanced Clear Cell Renal Cell Carcinoma studies

Phase 2 Studies for Advanced Clear Cell Renal Cell Carcinoma

🔵 Active, Not Recruiting Phase2

Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer

📍 Moffitt Cancer Center — Tampa, Florida

View Study & Checklist ➔

🟡 Not Yet Recruiting Phase2

RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

📍 City of Hope Medical Center — Duarte, California

View Study & Checklist ➔

🟢 Recruiting Phase2

VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma

📍 Mayo Clinic in Rochester — Rochester, Minnesota

View Study & Checklist ➔

🟢 Recruiting Phase2

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

📍 City of Hope National Medical Center — Duarte, California

View Study & Checklist ➔